Navigation Links
Cholesterol, Serum or Plasma

ProductsCholesterol, Serum or Plasma
Company ARUP Laboratories
Item Cholesterol, Serum or Plasma
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Cholesterol, Total
2. HDL Cholesterol, Direct Test
3. LDL Cholesterol, Direct Test
4. Cholesterol, HDL
5. LDL Cholesterol, Direct
6. SAFE-T-FILL Serum
7. SAFE-T-FILL Serum Mini Capillary Collection Tubes
8. SAFE-T-FILL Serum Gel Mini Capillary Collection Tubes
9. SAFE-T-FILL Serum Gel Capillary Collection Tubes
10. SAFE-T-FILL Serum Bili
11. SAFE-T-FILL Serum Bili Gel Capillary Collection Tubes
Poly stat Strep A is a lateral flow, one-step immunoassay for the rapid, qualitative detection of Group A Streptococcal antigen from throat swabs. The test is intended for use as an aid in the diagn
...he ProTime Microcoagulation System monitors warfar...ient self-testing. Enhancements include an easy-t...le and replaceable battery. Software updates incl... computer or be transmitted to a LIS or EMR databa...
...ince 1994 the CoaguChek System has been providing ...eeded most, at the point of care. , The CoaguChe... of patients self-testing when monitoring on Couma...m allows the user to obtain a result from a finger...
...he Instacup Multi-Drug Screen Panel is used for th...man urine. The Instacup Panel consists of a test c... test card is inserted and the sample sealed with ...ot necessary to remove the test card to read the r...
Medicine Products:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...nd to prevent heart attacks, but the little white ... A new study says aspirin and related painkillers ...ed to potentially deadly infections in people with...e presence of the microbe, called human cytomegalo...
...tion approved to treat both major strains of influ...able for the start of this flu season because prod...cation, Tamiflu Oral Suspension product, was suppo... informed the FDA of its production problems, but ...
...rewarning from severe periodontal disease than non...the Journal of periodontology.// Researchers from ...edicine compared 13 type 1 diabetic and 20 non-dia...pregnancy to examine the effects of periodontal in...
...the Hopkins Heart Institute, a blunt and apparentl...iac death. When it comes to accidents and sports i...le fear. According to researchers, at the a blow t...s. The researchers looked at 100 cases of a rare ...
Other Medicine News:
(Date:10/6/2008)... More than 60 percent of moderate to severe pati... percent achieved endoscopic remission at Week 10,...at the American College,of Gastroenterology (ACG) .../- UCB today presented data from a,la...provement in Crohn,s,disease (CD) with a biologic ...
(Date:10/6/2008)... Improved Pharmacokinetic Characteristics of Naltr...erability in Clinical Trials -, PHOENIX, Oct. 6 /...c.,(Nasdaq: OREX ), a biopharmaceutical company f...al nervous system-related disorders, today present...(R) (naltrexone SR /,bupropion SR), successfully a...
(Date:10/6/2008)... SEATTLE, Oct. 6 /- Dendr...nce call today, Monday, October 6, 2008 at 9:00 AM...rim analysis of its IMPACT,(IMmunotherapy for Pros...B),clinical trial of PROVENGE(R) (sipuleucel-T), t...otherapy for the treatment of advanced prostate,ca...
(Date:10/6/2008)... Recent study revealed that drinking polyphenol-...ith changes in appetite, energy intake or body,wei...ar consumption of 100%,polyphenol-rich Concord gra...s not associated with changes in appetite and was ...ew data presented at the 49th Annual Meeting of,th...
Breaking Medicine Technology:CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3New Source of Heart Stem Cells Found 22491 1New Source of Heart Stem Cells Found 22491 2RxPop com Wins 7th Annual Horizon Interactive Award 22487 1RxPop com Wins 7th Annual Horizon Interactive Award 22487 2Health and Beauty Come Full Circle 3A Chado En Brings Full Benefit of Japanese Green Tea to Spas 22483 1Health and Beauty Come Full Circle 3A Chado En Brings Full Benefit of Japanese Green Tea to Spas 22483 2Concuity Announces Partnership with Financial Healthcare Systems LLC 6148 1Concuity Announces Partnership with Financial Healthcare Systems LLC 6148 2Concuity Announces Partnership with Financial Healthcare Systems LLC 6148 3Concuity Announces Partnership with Financial Healthcare Systems LLC 6148 4
....J., April 19, 2007 /PRNewswire-FirstCall/ --,VioQ...opharmaceutical company focused on acquiring, deve...ds, announced data from its,preclinical studies of...r the treatment of solid and hematologic tumors.,P...April 2007,Annual Meeting of the American Associat...
...sitive Top-Line Phase III Results for,Keppra® ...n,Paediatric Patients from One Month to Less than ...2007 - UCB today announced,positive top-line resul...ti-centre, placebo-controlled study evaluating the...acetam) (20-50,mg/kg/day) as adjunctive therapy in...
Other Medicine Technology:VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 2UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 3UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 4UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 5